未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial维奈克拉联合HAG方案在新诊断ETP-ALL中的应用：一项前瞻性、多中心、II期临床试验
Suo, Shanshan; Lu, Ying; Yu, Wenjuan; Yang, Chunmei; Shen, Lijing; Pei, Renzhi; Ni, Beiwen; Xie, Wanzhuo; Mao, Liping; Ye, Xingnong; Qian, Jiejing; Wang, Jin; Li, Bingzong; Wang, Xiaomin; Li, Linjie; Zhao, Dan; Xia, Yongming; Shou, Lihong; Shao, Yanping; Gao, Da; Mai, Wenyuan; Zhou, De; Xu, Gaixiang; Yang, Min; Lou, Yinjun; Tong, Hongyan; Wang, Huafeng; Jin, Jie 分享 收藏 A Novel Prognostic Model for Adult Acute Myeloid Leukemia Patients with NPM1 Mutation一种新型预后模型，用于NPM1突变型成人急性髓系白血病患者Yao, Yiyi; Zhou, Yile; Zhuo, Nanfang; Xie, Wanzhuo; Meng, Haitao; Lou, Yinjun; Mao, Liping; Tong, Hongyan; Qian, Jiejing; Yang, Min; Yu, Wenjuan; Zhou, De; Huang, Jian; Jin, Jie; Wang, Huafeng 分享 收藏 Azacitidine, Homoharringtonine and Cytarabine Combined with Granulocyte Colony-Stimulating Factor As Frontline Treatment for Older Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase III Study in China阿扎胞苷、高三尖杉酯碱和吉西他滨联合粒细胞集落刺激因子作为老年急性髓系白血病患者的初始治疗方案：一项在中国进行的预期性、多中心、单臂III期研究Ma, Yafang; Zhang, Xiang; Hou, Jian; Shen, Lijing; Li, Fei; Kong, Fancong; Lu, Ying; Li, Guowei; Jin, Jie; Yu, Wenjuan 分享 收藏 Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trialLin, Ningjing; Sun, Xiuhua; Zhou, Hui; Zou, Liqun; Zhou, Keshu; Liu, Lihong; Yang, Haiyan; Hu, Kai; Cai, Qingqing; Liu, Yao; Jin, Jie; Zhang, Liling; Li, Wenyu; Guo, Ye; Yang, Wei; Luo, Feng; Wang, Zhenguang; Zhu, Rong; Yang, Lei; Song, Dan; Song, Yuqin; Zhu, Jun 分享 收藏 Orelabrutinib combined with rituximab for the treatment of elderly patients with newly diagnosed non-GCB diffuse large B-cell lymphoma (DLBCL) under the guidance of genetic subtype: A prospective, multicenter, single-arm, response-adaptive clinical study (Origin)奥雷巴替尼联合利妥昔单抗治疗新诊断非GCB型弥漫大B细胞淋巴瘤（DLBCL）老年患者：基于遗传亚型的前瞻性、多中心、单臂、反应适应性临床研究（Origin）Xie, W.; Zheng, X.; Zhou, D.; Shi, Y.; Wang, J.; Sun, J.; Yang, C.; Hu, C.; Yu, W.; Tong, H.; Jin, J. 分享 收藏 Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trialMei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Shen, Xuliang; Jin, Jie; Luo, Jianmin; Zeng, Yun; Zhou, Xin; Xia, Ruixiang; Jiang, Zhongxing; Bai, Yuansong; Niu, Ting; Yang, Renchi; Hu, Yu 分享 收藏 Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: multicentre retrospective study从原发性血小板增多症到原发性血小板增多症后骨髓纤维化早期预测模型的开发和验证: 多中心回顾性研究Xiang, Danhong; Yang, Xiudi; Qian, Honglan; Zhang, Li; Han, Yanxia; Sun, Yongcheng; Lu, Ying; Chen, Yu; Cao, Dan; Hu, Meiwei; Wang, Lifeng; Tang, Qinli; Wu, Dijiong; Tian, Guoyan; Tong, Hongyan; Jin, Jie; Huang, Jian 分享 收藏 分享 收藏 分享 收藏 A global study for acute myeloid leukemia with RARG rearrangementZhu, Hong-Hu; Qin, Ya-Zhen; Zhang, Zhang-Lin; Liu, Yong-Jing; Wen, Li-Jun; You, M. James; Zhang, Cheng; Such, Esperanza; Luo, Hong; Yuan, Hong-Jian; Zhou, Hong-Sheng; Liu, Hong-Xing; Xu, Reng; Li, Ji; Li, Jian-Hu; Hao, Jian-Ping; Jin, Jie; Yu, Liang; Zhang, Jing-Ying; Liu, Li-Ping; Zhang, Le-Ping; Huang, Rui-Bin; Shen, Shu-Hong; Gao, Su-Jun; Wang, Wei; Yan, Xiao-Jing; Zhang, Xin-You; Du, Xin; Chu, Xiao-Xia; Yu, Yan-Fang; Wang, Yi; Mi, Ying-Chang; Lu, Ying; Cai, Zhen; Su, Zhan; Taussig, David Christopher; MacMahon, Suzanne; Ball, Edward D.; Wang, Huan-You; Welch, John S.; Yin, C. Cameron; Borthakur, Gautam; Sanz, Miguel A.; Kantarjian, Hagop M.; Huang, Jin-Yan; Hu, Jiong; Chen, Su-Ning 分享 收藏 A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera一种新的alfa-2b干扰素的给药方案是高度有效和可耐受的: 来自中国真性红细胞增多症患者的2期研究的结果Jin, Jie; Zhang, Lei; Qin, Albert; Wu, Daoxiang; Shao, Zonghong; Bai, Jie; Chen, Suning; Duan, Minghui; Zhou, Hu; Xu, Na; Zhang, Sujiang; Zuo, Xuelan; Du, Xin; Wang, Li; Li, Pei; Zhang, Xuhan; Li, Yaning; Zhang, Jingjing; Wang, Wei; Shen, Weihong; Zagrijtschuk, Oleh; Urbanski, Raymond; Sato, Toshiaki; Xiao, Zhijian 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
